1. Home
  2. IMNM vs LUNR Comparison

IMNM vs LUNR Comparison

Compare IMNM & LUNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • LUNR
  • Stock Information
  • Founded
  • IMNM 2006
  • LUNR 2013
  • Country
  • IMNM United States
  • LUNR United States
  • Employees
  • IMNM N/A
  • LUNR 435
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • LUNR Industrial Machinery/Components
  • Sector
  • IMNM Health Care
  • LUNR Industrials
  • Exchange
  • IMNM Nasdaq
  • LUNR Nasdaq
  • Market Cap
  • IMNM 945.8M
  • LUNR 1.1B
  • IPO Year
  • IMNM 2020
  • LUNR N/A
  • Fundamental
  • Price
  • IMNM $9.01
  • LUNR $9.33
  • Analyst Decision
  • IMNM Strong Buy
  • LUNR Buy
  • Analyst Count
  • IMNM 8
  • LUNR 7
  • Target Price
  • IMNM $24.75
  • LUNR $13.71
  • AVG Volume (30 Days)
  • IMNM 1.0M
  • LUNR 5.2M
  • Earning Date
  • IMNM 11-12-2025
  • LUNR 11-13-2025
  • Dividend Yield
  • IMNM N/A
  • LUNR N/A
  • EPS Growth
  • IMNM N/A
  • LUNR N/A
  • EPS
  • IMNM N/A
  • LUNR N/A
  • Revenue
  • IMNM $12,589,000.00
  • LUNR $225,977,000.00
  • Revenue This Year
  • IMNM N/A
  • LUNR $13.03
  • Revenue Next Year
  • IMNM $154.73
  • LUNR $45.16
  • P/E Ratio
  • IMNM N/A
  • LUNR N/A
  • Revenue Growth
  • IMNM 16.74
  • LUNR 42.86
  • 52 Week Low
  • IMNM $5.15
  • LUNR $5.34
  • 52 Week High
  • IMNM $16.73
  • LUNR $24.95
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 43.25
  • LUNR 53.36
  • Support Level
  • IMNM $9.01
  • LUNR $8.73
  • Resistance Level
  • IMNM $9.63
  • LUNR $9.42
  • Average True Range (ATR)
  • IMNM 0.71
  • LUNR 0.40
  • MACD
  • IMNM -0.07
  • LUNR 0.17
  • Stochastic Oscillator
  • IMNM 17.38
  • LUNR 80.85

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About LUNR Intuitive Machines Inc.

Intuitive Machines Inc is a space exploration, infrastructure, and services company. It is a diversified space company focused on space exploration. It supplies space products and services to support sustained robotic and human exploration to the Moon, Mars, and beyond. Its products and services are offered through its four business units: Lunar Access Services, Orbital Services, Lunar Data Services, and Space Products and Infrastructure. The Company operates in one operating segment and one reportable segment underpinned by three core pillars (delivery services, data transmission services, and infrastructure as a service) that have similar capabilities, customers, and economic characteristics. Revenue is from contracts with customers of orbital and lunar access services.

Share on Social Networks: